1. Emerging concepts on drug resistance in bladder cancer: Implications for future strategies
   Francesco Massari et al, 2015, Critical Reviews in Oncology/Hematology CrossRef
2. Smad4 Loss in Mouse Keratinocytes Leads to Increased Susceptibility to UV Carcinogenesis with Reduced Ercc1-Mediated DNA Repair
   Doyel Mitra et al, 2013, Journal of Investigative Dermatology CrossRef
3. Predictive Value of Ercc1 and Xpd Polymorphisms for Clinical Outcomes of Patients Receiving Neoadjuvant Therapy
   Mao Qixing et al, 2015, Medicine CrossRef
4. Individualized chemotherapy for osteosarcoma and identification of gene mutations in osteosarcoma
   Xin Xiao et al, 2015, Tumor Biology CrossRef
5. Prognostic role of Twist or Snail in various carcinomas: a systematic review and meta‐analysis
   Ping Zhang et al, 2014, European Journal of Clinical Investigation CrossRef
6. Waiting in the wings: the emerging role of molecular biomarkers in bladder cancer
   Dafina Ilijazi et al, 2018, Expert Review of Molecular Diagnostics CrossRef
7. ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis
   Yuksel Urun et al, 2017, Critical Reviews in Oncology/Hematology CrossRef
8. Biomarkers determining treatment tactics in metastatic urothelial cancer
   L. Yu. Grivtsova et al, 2023, Cancer Urology CrossRef
9. Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?
   Sebastiano Buti et al, 2015, Future Oncology CrossRef
10. Clinical Perspectives of ERCC1 in Bladder Cancer
    Konstantinos Koutsoukos et al, 2020, International Journal of Molecular Sciences CrossRef
11. ERCC1 and its role in tumor pathogenesis and progression
    Shailendra Kapoor, 2013, Urologic Oncology: Seminars and Original Investigations CrossRef
12. Snail1 expression in colorectal cancer and its correlation with clinical and pathological parameters
    Feride Kroepil et al, 2013, BMC Cancer CrossRef
13. Molecular determinants of response to cisplatin-based neoadjuvant chemotherapy
    Joaquim Bellmunt et al, 2013, Current Opinion in Urology CrossRef
14. Predictors of response to neoadjuvant therapy in urothelial cancer
    Nishita Tripathi et al, 2024, Critical Reviews in Oncology/Hematology CrossRef
15. Lessons learned from SMAD4 loss in squamous cell carcinomas
    Ariel L. Hernandez et al, 2019, Molecular Carcinogenesis CrossRef